Source link : https://www.newshealth.biz/health-news/should-i-prescribe-liraglutide-to-a-6-year-old-patient-with-obesity-if-fda-approved/
Muth is a primary care pediatrician and obesity medicine specialist. As a pediatric obesity medicine specialist, I have witnessed first-hand the benefits of GLP-1 receptor agonists in the treatment of adolescent obesity. In particular, semaglutide (Wegovy) plus intensive health behavior lifestyle treatment has improved comorbid health risk factors, physical activity tolerance, sleep, body image, and […]
Author : News Health
Publish date : 2024-10-06 16:00:00
Copyright for syndicated content belongs to the linked Source.